Hebert, A., Glaab, D., & Schreiber, R. (2019). A Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, 3(2), 171. https://doi.org/10.25251/skin.3.2.11